Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.
The current price of ITRM is 1.59 USD — it has increased by 1.92% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Iterum Therapeutics plc stocks are traded under the ticker ITRM.
Iterum Therapeutics plc is going to release the next earnings report on Mar 28, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Iterum Therapeutics plc has a max estimate of 7.00 USD and a min estimate of 6.00 USD.
Like other stocks, ITRM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Iterum Therapeutics plc stock right from TradingView charts — choose your broker and connect to your account.
ITRM reached its all-time high on Jun 8, 2018 with the price of 195.00 USD, and its all-time low was 0.60 USD and was reached on Dec 27, 2022. See other stocks reaching their highest and lowest prices.
As of Mar 28, 2024, the company has 14.00 employees. See our rating of the largest employees — is Iterum Therapeutics plc on this list?